Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony‐stimulating factor (G‐CSF): impact of age, sex, donor weight and type of G‐CSF used
- 31 July 2006
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 134 (5) , 517-525
Abstract
Summary: Mobilised peripheral blood is now the main source of stem cells collected from normal donors. We report our experience of mobilising and collecting 400 normal healthy donors using standardised procedures and techniques. Target recipient doses were reached with one aphaeresis in 63% of donors and with two aphaereses in 81% of donors. Approximately 2% of donors yielded such low progenitor values that they were termed ‘poor mobilisers’. There were minor effects of donor age, weight and sex and where possible, larger male donors under the age of 55 years should be selected. Two forms of granulocyte colony‐stimulating factor (G‐CSF) were used at the same dose and no significant difference was seen in the yield of CD34+ cells collected/l of blood processed. However, a greater number of granulocyte‐macrophage colony‐forming cells were harvested using lenograstim (glycosylated G‐CSF) compared with filgrastim (non‐glycosylated G‐CSF; P = 0·002). CD34+ cell yields were also measured halfway through the aphaeresis procedure. This was found to be highly predictive of final yield and facilitated distribution of the stem cell product to other centres. The observation that CD34+ yields did not decline in the second half compared with the first half of aphaeresis suggests that the circulating cell numbers are not static.Keywords
This publication has 38 references indexed in Scilit:
- Weighing the risks of G‐CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donorsPediatric Blood & Cancer, 2006
- Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003Bone Marrow Transplantation, 2005
- Second donation of granulocyte–colony‐stimulating factor–mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cellsTransfusion, 2004
- Analysis of factors associated with low peripheral blood progenitor cell collection in normal donorsTransfusion, 2002
- Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databasesBone Marrow Transplantation, 2001
- A randomized comparison of once versus twice daily recombinant human granulocyte colony‐stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantationBritish Journal of Haematology, 2000
- Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantationBone Marrow Transplantation, 1998
- Collection and Recruitment of CD34+ Cells During Large-Volume LeukapheresisJournal of Hematotherapy, 1997
- Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collectionsBritish Journal of Haematology, 1997
- STEM CELL MOBILIzATION IN NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION: ANALYSIS OF SAFETY AND FACTORS AFFECTING EFFICACYBritish Journal of Haematology, 1996